Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in subjects with type 2 diabetes (SUSTAIN 1). (October 2016) - Harasfflma, Shin-ichi; Sorli, Christopher; Tsoukas, George; Unger, Jeffrey; Karsbøl, Julie Derving; Hansen, Thomas; Bain, Stephen